Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1995
12/21/1995WO1995034648A1 A method for displaying proteins
12/21/1995WO1995034635A1 Nucleic acid sequences and expression systems for heparinase ii and heparinase iii derived from flavobacterium heparinum
12/21/1995WO1995034581A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
12/21/1995WO1995034580A1 Isolated nucleic acid encoding retinol dehydrogenase
12/21/1995WO1995034578A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments
12/21/1995WO1995034558A1 Chondramides, production methods, compositions comprising chondramides and cultures for chondramide production
12/21/1995WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995WO1995034320A2 Methods for inhibiting antigen specific t cell responses
12/21/1995WO1995034319A1 Compositions and methods for the treatment of tumors
12/21/1995WO1995034201A1 pp60PIK: A DOWNSTREAM ELEMENT IN INSULIN SIGNALING
12/21/1995WO1995033048A3 P2x receptors (purinoceptor family)
12/21/1995WO1995030750A3 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
12/21/1995WO1995029245A3 Btf2 complex proteins and uses thereof
12/21/1995WO1995020660A3 Immunization by inoculation of dna transcription unit
12/21/1995CA2193072A1 Corticotropin-releasing factor2 receptors
12/21/1995CA2193060A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
12/21/1995CA2192844A1 Fas associated proteins
12/21/1995CA2192486A1 Pp60pik: a downstream element in insulin signaling
12/21/1995CA2192334A1 Isolated nucleic acid encoding retinol dehydrogenase
12/21/1995CA2192175A1 Surface protein of staphylococcus aureus
12/21/1995CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995CA2191733A1 Methods for inhibiting antigen specific t cell responses
12/21/1995CA2191065A1 Compositions and methods for the treatment of tumors
12/21/1995CA2169358A1 A method for displaying proteins
12/20/1995EP0687303A1 Improved feedcrops enriched in sulfur amino acids and methods for improvement
12/20/1995EP0687302A1 Bi-functional expression system
12/20/1995EP0687301A1 Prohormone convertase transformed cells and polypeptide synthesis
12/20/1995EP0687300A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION
12/20/1995EP0687295A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
12/20/1995EP0687272A1 Method and compositions for recombinant osteogenic protein production
12/20/1995EP0687271A1 Extraction of cell-bound protein from bordetella
12/20/1995EP0669933A4 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3.
12/20/1995EP0502036B1 Latency associated peptide and uses therefor
12/20/1995EP0394424B1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes
12/20/1995CN1113518A A novel peptide related to human programmed cell death and DNA encoding it
12/20/1995CN1030528C Human placenta collagen and preparation thereof
12/19/1995US5476939 Immunoassay for metal ions; forming coordination complexes
12/19/1995US5476786 Host cell harboring and capable of expressing DNA encoding single chain recombinant polypeptide having site for binding preselected antigen
12/19/1995US5476782 DNA encoding a human 5-HT1E receptor and uses thereof
12/19/1995US5476781 Genetic engineering
12/19/1995US5476773 Of protein; then mixing with a reducing sugar
12/19/1995CA2011654C Recombinant poxvirus host range selection system
12/19/1995CA1337759C Glycopeptide antibiotic
12/19/1995CA1337758C Peptide antibiotics
12/19/1995CA1337756C Means and method for preventing and treating graft failure in humans
12/19/1995CA1337755C Monoclonal antibodies for human non-small cell lung carcinomas
12/18/1995CA2151627A1 Recombinant gibberellin dna and uses thereof
12/15/1995CA2150994A1 P53as protein and antibody therefor
12/14/1995WO1995033855A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof
12/14/1995WO1995033844A1 Method for producing heterologous bispecific antibodies
12/14/1995WO1995033843A1 Deblocking the common pathway of aromatic amino acid synthesis
12/14/1995WO1995033833A1 Yeast strains
12/14/1995WO1995033832A1 Recombinant single chain fv antibody fragment and its use in the immunopurification of the recombinant hepatitis b virus surface antigen
12/14/1995WO1995033831A1 Methods and compositions for modulating morphogenic protein expression
12/14/1995WO1995033830A1 Bmp-9 compositions
12/14/1995WO1995033829A1 Pantropic neurotrophic factors
12/14/1995WO1995033825A1 A method of cultivating bacteria producing proteins that are expressed in a temperature regulated manner
12/14/1995WO1995033823A1 Methods for selectively stimulating proliferation of t cells
12/14/1995WO1995033818A2 Genes for the synthesis of antipathogenic substances
12/14/1995WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
12/14/1995WO1995033771A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
12/14/1995WO1995033770A1 Ligands for induction of antigen specific apoptosis in t cells
12/14/1995WO1995033758A1 Novel glyceroglycophospholipid, antibody there against, and method of detecting mycoplasma
12/14/1995WO1995033481A1 Diphtheria toxin vaccines bearing a mutated r domain
12/14/1995WO1995033480A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
12/14/1995WO1995031564A3 Method of introducing pathogen resistance in plants
12/14/1995WO1995030003A3 Morphogenic protein-specific cell surface receptors and uses therefor
12/14/1995CA2704083A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
12/14/1995CA2192370A1 Monoclonal antibody active against cd44v6
12/14/1995CA2192366A1 Genes for the synthesis of antipathogenic substances
12/14/1995CA2191728A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof
12/14/1995CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells
12/14/1995CA2191586A1 Methods for selectively stimulating proliferation of t cells
12/14/1995CA2191239A1 Diphtheria toxin vaccines bearing a mutated r domain
12/13/1995EP0686696A1 Recombinant single chain Fv antibody fragment and its use in the immunopurification of the recombinant Hepatitis B Virus Surface Antigen
12/13/1995EP0686397A2 Use of chondroitin sulphate proteoglycans for protection of neurons
12/13/1995EP0686260A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
12/13/1995EP0686203A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
12/13/1995EP0686195A1 Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria
12/13/1995EP0686194A1 Harp family growth factors, preparation methods therefor and uses thereof
12/13/1995EP0686162A1 Improved method for the refolding of proteins
12/13/1995EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT
12/13/1995EP0686044A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors
12/13/1995EP0359771B1 Lepidopteran and coleopteran active microorganisms, related insecticide compositions and methods for their production and use
12/13/1995CN1113389A High molecular weight desulphatohirudin
12/12/1995US5475100 An antibody having antigen binding activity and which has a heavy chain constant region into which has been inserted arganine-glycine-aspartic acid and serine amino acid sequence, giving antibody affinity for cells
12/12/1995US5475087 Polypeptides
12/12/1995US5474930 Non-tumorigenic cell lines for expression of genes
12/12/1995US5474925 Creating genetic construction for expression of enzyme in cotton plant, transforming into inheritable material of plant, cultivating plant, harvesting seed floss fiber with enzyme immobilized therein, performing reaction with enzyme catalyst
12/12/1995US5474914 Method of producing secreted CMV glycoprotein H
12/12/1995US5474913 Process for the preparation of motilin-like polypeptide and expression thereof
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/12/1995CA1337717C Monoclonal antibodies against human necrosis factor (tnf) _ use thereof for detecting tnf in samples, and pharmaceutical compositions containing them
12/09/1995CA2151117A1 A process for producing a thiol protease inhibitor derived from a microorganism belonging to the genus aspergillus
12/07/1995WO1995033297A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch
12/07/1995WO1995033059A2 Receptor for oncostatin m
12/07/1995WO1995033057A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation
12/07/1995WO1995033053A1 Hepatitis c virus asialoglycoproteins
12/07/1995WO1995033052A1 Immunosuppressant target proteins
12/07/1995WO1995033051A1 Tumor necrosis factor receptor-associated factors